geko.health

VTE Prevention

Pilot Trial of Neuromuscular Stimulation in Human Subjects with Chronic Venous Disease
Author(s): Williams K J, Moore H M, Ellis M, Davies A H
Introduction of the geko™ device at North Bristol Trust UK
Author(s): Hitchcock K, Austin L
Further update on the role of geko™ in reducing the risk of venous thromboembolism (VTE) in Obstetrics
Author(s): M. Andrzejowska, B Godwin, M Fawzy
Prediction and prophylaxis of postoperative thromboembolis—a comparison between peroperative calf muscle stimulation with groups of impulses and dextran 40
Author(s): Lindström B, Holmdahl C, Jonsson O, Korsan‐Bengtsen K, Lindberg S, Petrusson B, Pettersson S, Wikstrand J, Wojciechowski J
Prophylaxis of postoperative leg vein thrombosis by low dose subcutaneous heparin or peroperative calf muscle stimulation: a controlled clinical trial.
Author(s): Rosenberg I L , Evans M, Pollock A V
The use of the geko™ device for the prevention of venous thromboembolism in patients with acute stroke at The Luton & Dunstable University Hospital (L&D)
Author(s): Nihara D, Sethuraman S, Sekaran L, Phiri D, Asokanathan A, Alwis L
Clinical observation of neuromuscular electrical stimulation in prevention of deep venous thrombosis after total hip replacement
Author(s): Jingwei L, Zhe Z, Xuesong L, Hui J, Ning L, Wenbo W
The role of the geko™ device to prevent Deep Vein Thrombosis (DVT) on a patient undergoing rehabilitation on the gastro-intestinal ward
Author(s): Wong C
geko™ device – Product Evaluation and Welsh Supply Chain Logistics – An Innovation case study
Author(s): Welsh Case Study
Acute Stroke Hospitalization and Deep Vein Thrombosis Prophylaxis: Gaps in Care and the Unmet Need
Author(s): Hairston M, Renati S, Platti N, Rose DZ